Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis

High‐Density Lipoprotein Subspecies Defined by Apolipoprotein C‐III and Subclinical Atherosclerosis Measures: MESA (The Multi‐Ethnic Study of Atherosclerosis)

(2018) Sarah A. Aroner et al.   Journal of the American Heart Association

High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts

(2017) Majken K. Jensen et al.   CIRCULATION

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

(2017) Meenakshi Sundaram et al.   JOURNAL OF LIPID RESEARCH

2. Classification and Diagnosis of Diabetes

(2016)   DIABETES CARE

The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia

(2015) Frank M. Sacks   CURRENT OPINION IN LIPIDOLOGY

HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study

(2015) Christiane L. Haase et al.   DIABETES

Lipoprotein Particles and Incident Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis

(2015) Rachel H. Mackey et al.   DIABETES CARE

The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis

(2015) Moritz C. Wyler von Ballmoos et al.   Journal of Clinical Lipidology

Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes

(2015) Karin Åvall et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Apolipoprotein C-III

(2015) Alison B. Kohan   Current Opinion in Endocrinology Diabetes and Obesity

Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

(2014) Anders Berg Jørgensen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Role of HDL Cholesterol and Estimates of HDL Particle Composition in Future Development of Type 2 Diabetes in the General Population: The PREVEND Study

(2013) Ali Abbasi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia

(2012) Janet D. Sparks et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The emerging role of HDL in glucose metabolism

(2012) Brian G. Drew et al.   Nature Reviews Endocrinology

Apolipoprotein C‐III as a Potential Modulator of the Association Between HDL‐Cholesterol and Incident Coronary Heart Disease

(2012) Majken K. Jensen et al.   Journal of the American Heart Association

Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart Disease

(2011) Carlos O. Mendivil et al.   CIRCULATION

Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance

(2011) Hui-Young Lee et al.   HEPATOLOGY

Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content

(2011) A Peter et al.   INTERNATIONAL JOURNAL OF OBESITY

Missense Mutation inAPOC3within the C-terminal Lipid Binding Domain of Human ApoC-III Results in Impaired Assembly and Secretion of Triacylglycerol-rich Very Low Density Lipoproteins

(2011) Wen Qin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Lowering apolipoprotein CIII delays onset of type 1 diabetes

(2011) R. Holmberg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype

(2010) Chunyu Zheng et al.   CIRCULATION

Lipoprotein Particle Size and Concentration by Nuclear Magnetic Resonance and Incident Type 2 Diabetes in Women

(2010) S. Mora et al.   DIABETES

Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease

(2010) Kitt Falk Petersen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum apolipoprotein C-III in high-density lipoprotein: a key diabetogenic risk factor in Turks

(2009) A. Onat et al.   DIABETIC MEDICINE

Low- and High-Density Lipoproteins Modulate Function, Apoptosis, and Proliferation of Primary Human and Murine Pancreatic β-Cells

(2009) Sabine Rütti et al.   ENDOCRINOLOGY

Dyslipidemia in type 2 diabetes mellitus

(2009) Arshag D Mooradian   Nature Reviews Endocrinology

A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection

(2008) T. I. Pollin et al.   SCIENCE